The global hypodermic needles market size was valued at $3,256.00 million in 2020, and is expected to garner $4,537.99 million by 2030, registering a CAGR of 3.4 % during the forecast period 2021-2030.
A hypodermic needle is a hollow needle widely used across medical settings to carry out different applications, such as drug delivery, vaccination, and blood specimen collection. These needles function through two different mechanisms, namely safety and non-safety needles. They are used to administer and inject drugs in the body and also to withdraw fluids from the body for examination and research purposes.
The growth of the global hypodermic needles market size is driven by increase in incidences of needlestick injuries. According to World Health Organization, it was estimated that 296 million people were living with chronic hepatitis B infection in 2019, with 1.5 million new infections each year in 2019. Hepatitis B resulted in an estimated 820, 000 deaths, and hundreds of thousands of healthcare workers were at high risk of work-related infections, such as hepatitis B, hepatitis C, and HIV due to exposure to contaminated needle sticks and sharp injuries. In addition, rise in incidence of chronic & lifestyle diseases, especially diabetes, supplements the hypodermic needles market growth. However, availability of alternative modes of drug delivery, low awareness towards safety syringes, and high cost of hypodermic needles hamper the hypodermic needles industry. Based on hypodermic needles market analysis, the untapped emerging economies present lucrative opportunities for the market.
The hypodermic needles market is segmented on the basis of product type, application, end user, and region. On the basis of product type, the market is bifurcated into safety and non-safety hypodermic needles. The safety hypodermic needles segment is sub-segmented on the basis of type and mode of activation.
By type, safety hypodermic needles are divided into retractable and nonretractable needles. By mode of activation, they are classified into active and passive hypodermic needles.
The safety hypodermic needle segment holds the largest market share owing to the technological advancements, prevention of needlestick injuries, and safety mechanisms embedded in these needles.
By applications, the market if divided into drug delivery, vaccination, and blood specimen collection. The drug delivery application was the highest revenue contributor in 2020. However, the vaccination segment is anticipated to grow at the highest rate during the forecast period owing to high birth rates and increase in awareness towards vaccination globally.
By end user, the hypodermic needles market includes hospitals, diabetic patient, family practitioner, psychiatry and others. World Health Organization (WHO) has recommended all healthcare providers to switch over to safer needles and helps prevent the spread of blood-borne diseases such as hepatitis, HIV, and viral hemorrhagic fevers. Hospitals are the largest end users of hypodermic needles. Hospitals that are publicly or privately owned, multinational hospitals, specialty hospitals, and others, widely use hypodermic needles for various purposes such as vaccination, drug delivery, blood specimen collection, and others.
Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Asia-Pacific accounted for the largest hypodermic needles market share in 2020, and is expected to maintain its dominance during the forecast period. This is attributed to higher buying power and stringent regulations that favor the utilization of hypodermic needles. In addition, increase in awareness towards the risk of cross infection (such as hepatitis, HIV, and AIDS) and needlestick injuries, boosts the adoption of safety hypodermic needles. Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to improvements in healthcare facilities, increase in disposable income, and rapid development of economic conditions.
The key players that operate in the global hypodermic needles market include, Becton, Dickinson and Company, B. Braun Melsungen Ag, Cardinal Health Inc., Connecticut Hypodermics Inc., Exelint International Co., Mckesson Corporation, Hi-tech syringes, Retractable Technologies, Inc., Nipro Corporation, and Terumo Medical Corporation.
A hypodermic needle is a hollow needle widely used across medical settings to carry out different applications, such as drug delivery, vaccination, and blood specimen collection. These needles function through two different mechanisms, namely safety and non-safety needles. They are used to administer and inject drugs in the body and also to withdraw fluids from the body for examination and research purposes.
The growth of the global hypodermic needles market size is driven by increase in incidences of needlestick injuries. According to World Health Organization, it was estimated that 296 million people were living with chronic hepatitis B infection in 2019, with 1.5 million new infections each year in 2019. Hepatitis B resulted in an estimated 820, 000 deaths, and hundreds of thousands of healthcare workers were at high risk of work-related infections, such as hepatitis B, hepatitis C, and HIV due to exposure to contaminated needle sticks and sharp injuries. In addition, rise in incidence of chronic & lifestyle diseases, especially diabetes, supplements the hypodermic needles market growth. However, availability of alternative modes of drug delivery, low awareness towards safety syringes, and high cost of hypodermic needles hamper the hypodermic needles industry. Based on hypodermic needles market analysis, the untapped emerging economies present lucrative opportunities for the market.
The hypodermic needles market is segmented on the basis of product type, application, end user, and region. On the basis of product type, the market is bifurcated into safety and non-safety hypodermic needles. The safety hypodermic needles segment is sub-segmented on the basis of type and mode of activation.
By type, safety hypodermic needles are divided into retractable and nonretractable needles. By mode of activation, they are classified into active and passive hypodermic needles.
The safety hypodermic needle segment holds the largest market share owing to the technological advancements, prevention of needlestick injuries, and safety mechanisms embedded in these needles.
By applications, the market if divided into drug delivery, vaccination, and blood specimen collection. The drug delivery application was the highest revenue contributor in 2020. However, the vaccination segment is anticipated to grow at the highest rate during the forecast period owing to high birth rates and increase in awareness towards vaccination globally.
By end user, the hypodermic needles market includes hospitals, diabetic patient, family practitioner, psychiatry and others. World Health Organization (WHO) has recommended all healthcare providers to switch over to safer needles and helps prevent the spread of blood-borne diseases such as hepatitis, HIV, and viral hemorrhagic fevers. Hospitals are the largest end users of hypodermic needles. Hospitals that are publicly or privately owned, multinational hospitals, specialty hospitals, and others, widely use hypodermic needles for various purposes such as vaccination, drug delivery, blood specimen collection, and others.
Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Asia-Pacific accounted for the largest hypodermic needles market share in 2020, and is expected to maintain its dominance during the forecast period. This is attributed to higher buying power and stringent regulations that favor the utilization of hypodermic needles. In addition, increase in awareness towards the risk of cross infection (such as hepatitis, HIV, and AIDS) and needlestick injuries, boosts the adoption of safety hypodermic needles. Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to improvements in healthcare facilities, increase in disposable income, and rapid development of economic conditions.
The key players that operate in the global hypodermic needles market include, Becton, Dickinson and Company, B. Braun Melsungen Ag, Cardinal Health Inc., Connecticut Hypodermics Inc., Exelint International Co., Mckesson Corporation, Hi-tech syringes, Retractable Technologies, Inc., Nipro Corporation, and Terumo Medical Corporation.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global hypodermic needles market analysis from 2020 to 2030 to identify the prevailing global hypodermic needles market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the global hypodermic needles market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global global hypodermic needles market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Products
- Safety Hypodermic Needles
- Non-safety Hypodermic Needles
By Application
- Drug Delivery
- Vaccination
- Blood Specimen Collection
By End Users
- Hospital
- Diabetic Patients
- Family Practitioners
- Psychiatry
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- "Rest Of Europe "
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan, Republic Of China
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Becton, Dickinson and Company
- B. BRAUN MELSUNGEN AG
- Cardinal Health Inc.
- CONNECTICUT HYPODERMICS INC.
- EXELINT INTERNATIONAL CO.
- McKesson Corporation
- Hitech Syringes
- Retractable Technologies, Inc.
- Nipro Corporation
- TERUMO MEDICAL CORPORATION
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: GLOBAL HYPODERMIC NEEDLES MARKET, BY PRODUCTS
CHAPTER 5: GLOBAL HYPODERMIC NEEDLES MARKET, BY APPLICATION
CHAPTER 6: GLOBAL HYPODERMIC NEEDLES MARKET, BY END USERS
CHAPTER 7: GLOBAL HYPODERMIC NEEDLES MARKET, BY REGION
CHAPTER 8: COMPANY LANDSCAPE
CHAPTER 9: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to this report titled, 'Global Hypodermic Needles Market: Opportunity Analysis and Industry Forecast, 2021-2030' the global Hypodermic Needles Market size was valued at $3.3 billion in 2020, and is estimated to reach $4.5 billion by 2030, growing at a CAGR of 3.4% from 2020 to 2030.A hypodermic needle is a hollow needle widely used across medical settings to carry out different applications, such as drug delivery, vaccination, and blood specimen collection. These needles function through two different mechanisms, namely safety and non-safety needles. They are used to administer and inject drugs in the body and also to withdraw fluids from the body for examination and research purposes.
Hypodermic needles also serve important roles in research requiring sterile conditions. The hypodermic needle significantly reduces contamination during inoculation of a sterile substrate in two ways. First, its surface is extremely smooth, preventing airborne pathogens from becoming trapped between irregularities on the needle’s surface, which could subsequently be transferred into the media as contaminants. Second, the needle’s point is extremely sharp, significantly reducing the diameter of the hole remaining after puncturing the membrane, which consequently prevents microbes larger than the hole from contaminating the substrate. Also because of increase in applications of hypodermic needles, especially in clinics, hospitals, and by physicians has formulated the need of regulatory guidelines to evaluate the performance and quality of these needles. The International Organization for Standardization (ISO) has formed safety standards for their commercial use. These regulations provide guidance to determine the specification and minimum standards for hypodermic needles.
Needlestick injuries have a significant impact on the Hypodermic Needles Industry, and this impact is projected to further increase during the forecast period. This is attributed to the fact that needlestick injuries are the leading cause of blood-borne disease among healthcare professionals. The government and private organizations are taking certain initiatives to make advancement in the Hypodermic Needles Industry to prevent injuries occurred by needles, which is expected to propel the growth of the hypodermic needles market size. For instance, in June 2020, Beckton, Dickinson and Company (BD,) a leading global medical technology company, launched new ultratouch push button blood collection set with pre-attached holder that will help protect healthcare workers from the needlestick injury.
Also, B. Braun Medical Inc. launched its heparin sodium injection, the first Heparin 0.5 mL prefilled syringe with attached safety needle for subcutaneous and intravenous use in the U.S., in august 2019.
In addition, rise in incidence of chronic & lifestyle diseases, especially diabetes, supplements the market growth. Increase in consumption of injectable drugs especially among diabetic patients and increase in preference of injectable drugs in comparison to oral drugs due to rapid onset & effective treatment drives the demand for hypodermic needles. In addition, rise in adoption of these needles for vaccination and immunization purposes is expected to boost the growth of the market.
Rise in incidence of chronic & lifestyle diseases, especially diabetes,, and increase in demand for advanced hypodermic needles solutions are expected to drive the Hypodermic Needles Market Growth. However, availability of alternative modes of drug delivery, low awareness towards safety syringes, and high cost of hypodermic needles hamper the market growth. The upsurge in demand for hypodermic needles, rise in disposable incomes, and growth prospects in emerging economies of Asia-Pacific and LAMEA are expected to provide numerous opportunities for market growth during the forecast period.
Depending on product type, the safety hypodermic needles segment dominated the market in 2020, and this trend is expected to continue during the forecast period, due to increase in prevalence of the needlestick injury. The safety hypodermic needles are widely preferred over non-safety hypodermic needles, owing to the convenience and safety offered by these products along with advanced features, such as luer lock, single-handed technique, and other safety features.
Depending on application, the drug delivery segment dominated the market in 2020, and this trend is expected to continue during the forecast period. The injections, which employ hypodermic needles provide high drug absorption and less wastage of drugs, shorter onset time and accurate titration of the dosage. During vaccination, hypodermic needles are used to deliver the vaccines to the patients to treat various conditions such as influenza, hepatitis, pneumonia, and others. For blood specimen collection, sterile hypodermic needles are used to avoid the needlestick injuries to the blood donors, receivers, and healthcare providers and the risk associated with cross infection associated with blood transfusion.
Depending on end user Hypodermic Needles Market Analysis, hospitals are the largest end users of hypodermic needles in 2020, and this trend is expected to continue during the forecast period. Hospitals widely use hypodermic needles for various purposes, such as vaccination, drug delivery, blood specimen collection, and others. Also, hospitals of developed countries have made it mandatory to use hypodermic needles. World Health Organization (WHO) has recommended all healthcare providers to switch over to safer needles to help prevent the spread of blood-borne diseases, such as hepatitis, HIV, and viral hemorrhagic fevers. There is increase in activities in the healthcare sector owing to high demand for hypodermic needles in hospitals and health maintenance organization HMOs globally. In addition, hospitals and health maintenance organization (HMO's) consistently collaborate with safety needle manufacturers, distributors, and organizations for medical supplies of hypodermic needles across all hospitals and HMOs.
Asia-Pacific garnered a major in the hypodermic needles market share in 2020, and is expected to continue to dominate during the forecast period, owing to increase in prevalence of chronic diseases, presence of a high population base (with India and China being the most populated countries), presence of unmet medical needs, and increase in disposable incomes of people in this region. However, based on Hypodermic Needles Market Forecast, Europe is expected to register second highest share in 2020, owing to increase in prevalence diabetes, presence of key players in region, and well developed healthcare infrastructure in this region.
Companies Mentioned
- Becton, Dickinson and Company
- B. BRAUN MELSUNGEN AG
- Cardinal Health Inc.
- CONNECTICUT HYPODERMICS INC.
- EXELINT INTERNATIONAL CO.
- McKesson Corporation
- Hitech Syringes
- Retractable Technologies, Inc.
- Nipro Corporation
- TERUMO MEDICAL CORPORATION
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
